about
Essential Tremor: What We Can Learn from Current PharmacotherapySuccinate is an inflammatory signal that induces IL-1β through HIF-1α.Vigabatrin-induced MRI changes associated with extrapyramidal symptoms in a child with infantile spasms.Mechanism of action of vigabatrin: correcting misperceptions.Vigabatrin therapy for refractory complex partial seizures: review of major European trials.Vigabatrin therapy for refractory complex partial seizures: review of clinical trial experience in the United States.Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosing.Understanding and interpreting vision safety issues with vigabatrin therapy.Balancing clinical benefits of vigabatrin with its associated risk of vision loss.Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent.Neurobehavioral effects of vigabatrin and its ability to induce DNA damage in brain cells after acute treatment in rats.A prospective study contrasting the psychiatric outcome in drug-resistant epilepsy between patients who underwent surgery and a control group.Effect of vigabatrin on seizure control and safety profile in different subgroups of children with epilepsy.Vigabatrin 35 years later - from mechanism of action to benefit-risk considerations.
P2860
Q26753840-5560E89B-A9B4-49BD-9690-C375364B80D6Q33652731-C10E4F18-7C11-42E7-933A-4DC532613150Q36589846-A1FFA65B-29BA-400A-A6A0-D7CB7D000E9EQ37953574-390D647B-2E09-493A-8C0D-9F86BC19CFCFQ37953576-FD119E1D-6C67-4BE4-8146-2906234B7006Q37953578-243CA6BA-BB57-4501-83D0-68108F95C990Q37953579-48DFCAB9-2B2D-4A29-88B8-B3EAAFD3C1CFQ37953582-ADCFB98C-93A7-4ADC-AA51-D11C3510D0B8Q37953583-DD0D4314-1DDE-4898-8DAF-ABF6E770596BQ38946574-85C4CDE3-0D11-4601-B420-8854EE6AC126Q47396699-56AF6D1B-17FE-4F7D-A401-A1CE0DA26FF2Q47953079-727B328D-A3FD-450E-9997-0DDBE2A8C93CQ48203894-0561D3EA-9954-4B2A-8988-0698AC071326Q48552376-7AD519EF-E52A-4A4F-A8A4-204CC24C97A2
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Non-vision adverse events with vigabatrin therapy.
@ast
Non-vision adverse events with vigabatrin therapy.
@en
Non-vision adverse events with vigabatrin therapy.
@nl
type
label
Non-vision adverse events with vigabatrin therapy.
@ast
Non-vision adverse events with vigabatrin therapy.
@en
Non-vision adverse events with vigabatrin therapy.
@nl
prefLabel
Non-vision adverse events with vigabatrin therapy.
@ast
Non-vision adverse events with vigabatrin therapy.
@en
Non-vision adverse events with vigabatrin therapy.
@nl
P2860
P1476
Non-vision adverse events with vigabatrin therapy.
@en
P2093
R Kälviäinen
S D Walker
P2860
P356
10.1111/J.1600-0404.2011.01602.X
P577
2011-01-01T00:00:00Z